Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease
Identifieur interne : 002D15 ( Main/Exploration ); précédent : 002D14; suivant : 002D16Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease
Auteurs : Kerrie L. Schoffer [Australie] ; Robert D. Henderson [Australie] ; Karen O'Maley [Australie] ; John D. O'Sullivan [Australie]Source :
- Movement Disorders [ 0885-3185 ] ; 2007-08-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Anti-Inflammatory Agents (therapeutic use), Blood Pressure (drug effects), Blood Pressure (physiology), Cross-Over Studies, Domperidone, Domperidone (therapeutic use), Dopamine Antagonists (therapeutic use), Double-Blind Method, Female, Fludrocortisone, Fludrocortisone (therapeutic use), Humans, Hypotension, Orthostatic (diagnosis), Hypotension, Orthostatic (etiology), Hypotension, Orthostatic (therapy), Male, Middle Aged, Nervous system diseases, Parkinson Disease (complications), Parkinson Disease (therapy), Parkinson disease, Parkinson's disease, Patient Compliance, Postural hypotension, Retrospective Studies, Severity of Illness Index, Sphygmomanometers, Tilt-Table Test (methods), Treatment, domperidone, fludrocortisone, nonpharmacological therapy, orthostatic hypotension.
- MESH :
- chemical , therapeutic use : Anti-Inflammatory Agents, Domperidone, Dopamine Antagonists, Fludrocortisone.
- complications : Parkinson Disease.
- diagnosis : Hypotension, Orthostatic.
- drug effects : Blood Pressure.
- etiology : Hypotension, Orthostatic.
- methods : Tilt-Table Test.
- physiology : Blood Pressure.
- therapy : Hypotension, Orthostatic, Parkinson Disease.
- Aged, Aged, 80 and over, Cross-Over Studies, Double-Blind Method, Female, Humans, Male, Middle Aged, Patient Compliance, Retrospective Studies, Severity of Illness Index, Sphygmomanometers.
Abstract
There is limited evidence for the treatment of orthostatic hypotension in idiopathic Parkinson's disease. The objective of this study was to determine the efficacy of three treatments (nonpharmacological therapy, fludrocortisone, and domperidone). Phase I assessed the compliance, safety, and efficacy of nonpharmacological measures. Phase II was a double‐blind randomized controlled crossover trial of the two medications. Primary outcome measures consisted of the orthostatic domain of the Composite Autonomic Symptom Scale (COMPASS‐OD), a clinical global impression of change (CGI), and postural blood pressure testing via bedside sphygmomanometry (Phase I) or tilt table testing (Phase II). For the 17 patients studied, nonpharmacological therapy did not significantly alter any outcome measure. Both medications improved the CGI and COMPASS‐OD scores. There was a trend towards reduced blood pressure drop on tilt table testing, with domperidone having a greater effect. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21428
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C93
- to stream Istex, to step Curation: 001C93
- to stream Istex, to step Checkpoint: 001823
- to stream PubMed, to step Corpus: 002651
- to stream PubMed, to step Curation: 002651
- to stream PubMed, to step Checkpoint: 002687
- to stream Ncbi, to step Merge: 001C88
- to stream Ncbi, to step Curation: 001C88
- to stream Ncbi, to step Checkpoint: 001C88
- to stream Main, to step Merge: 003C37
- to stream PascalFrancis, to step Corpus: 001573
- to stream PascalFrancis, to step Curation: 001748
- to stream PascalFrancis, to step Checkpoint: 001564
- to stream Main, to step Merge: 004154
- to stream Main, to step Curation: 002D15
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease</title>
<author><name sortKey="Schoffer, Kerrie L" sort="Schoffer, Kerrie L" uniqKey="Schoffer K" first="Kerrie L." last="Schoffer">Kerrie L. Schoffer</name>
</author>
<author><name sortKey="Henderson, Robert D" sort="Henderson, Robert D" uniqKey="Henderson R" first="Robert D." last="Henderson">Robert D. Henderson</name>
</author>
<author><name sortKey="O Maley, Karen" sort="O Maley, Karen" uniqKey="O Maley K" first="Karen" last="O'Maley">Karen O'Maley</name>
</author>
<author><name sortKey="O Sullivan, John D" sort="O Sullivan, John D" uniqKey="O Sullivan J" first="John D." last="O'Sullivan">John D. O'Sullivan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:29167FC968A8A883DC9A9FDAF9A429074AD4225F</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21428</idno>
<idno type="url">https://api.istex.fr/document/29167FC968A8A883DC9A9FDAF9A429074AD4225F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C93</idno>
<idno type="wicri:Area/Istex/Curation">001C93</idno>
<idno type="wicri:Area/Istex/Checkpoint">001823</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Schoffer K:nonpharmacological:treatment:fludrocortisone</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17557339</idno>
<idno type="wicri:Area/PubMed/Corpus">002651</idno>
<idno type="wicri:Area/PubMed/Curation">002651</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002687</idno>
<idno type="wicri:Area/Ncbi/Merge">001C88</idno>
<idno type="wicri:Area/Ncbi/Curation">001C88</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001C88</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Schoffer K:nonpharmacological:treatment:fludrocortisone</idno>
<idno type="wicri:Area/Main/Merge">003C37</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:07-0448787</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001573</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001748</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001564</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Schoffer K:nonpharmacological:treatment:fludrocortisone</idno>
<idno type="wicri:Area/Main/Merge">004154</idno>
<idno type="wicri:Area/Main/Curation">002D15</idno>
<idno type="wicri:Area/Main/Exploration">002D15</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease</title>
<author><name sortKey="Schoffer, Kerrie L" sort="Schoffer, Kerrie L" uniqKey="Schoffer K" first="Kerrie L." last="Schoffer">Kerrie L. Schoffer</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Henderson, Robert D" sort="Henderson, Robert D" uniqKey="Henderson R" first="Robert D." last="Henderson">Robert D. Henderson</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Queensland, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Maley, Karen" sort="O Maley, Karen" uniqKey="O Maley K" first="Karen" last="O'Maley">Karen O'Maley</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Sullivan, John D" sort="O Sullivan, John D" uniqKey="O Sullivan J" first="John D." last="O'Sullivan">John D. O'Sullivan</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Queensland, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-08-15">2007-08-15</date>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1543">1543</biblScope>
<biblScope unit="page" to="1549">1549</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">29167FC968A8A883DC9A9FDAF9A429074AD4225F</idno>
<idno type="DOI">10.1002/mds.21428</idno>
<idno type="ArticleID">MDS21428</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Anti-Inflammatory Agents (therapeutic use)</term>
<term>Blood Pressure (drug effects)</term>
<term>Blood Pressure (physiology)</term>
<term>Cross-Over Studies</term>
<term>Domperidone</term>
<term>Domperidone (therapeutic use)</term>
<term>Dopamine Antagonists (therapeutic use)</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Fludrocortisone</term>
<term>Fludrocortisone (therapeutic use)</term>
<term>Humans</term>
<term>Hypotension, Orthostatic (diagnosis)</term>
<term>Hypotension, Orthostatic (etiology)</term>
<term>Hypotension, Orthostatic (therapy)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Patient Compliance</term>
<term>Postural hypotension</term>
<term>Retrospective Studies</term>
<term>Severity of Illness Index</term>
<term>Sphygmomanometers</term>
<term>Tilt-Table Test (methods)</term>
<term>Treatment</term>
<term>domperidone</term>
<term>fludrocortisone</term>
<term>nonpharmacological therapy</term>
<term>orthostatic hypotension</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term>
<term>Domperidone</term>
<term>Dopamine Antagonists</term>
<term>Fludrocortisone</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hypotension, Orthostatic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Blood Pressure</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hypotension, Orthostatic</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Tilt-Table Test</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Blood Pressure</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hypotension, Orthostatic</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cross-Over Studies</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Patient Compliance</term>
<term>Retrospective Studies</term>
<term>Severity of Illness Index</term>
<term>Sphygmomanometers</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dompéridone</term>
<term>Fludrocortisone</term>
<term>Hypotension artérielle orthostatique</term>
<term>Parkinson maladie</term>
<term>Système nerveux pathologie</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There is limited evidence for the treatment of orthostatic hypotension in idiopathic Parkinson's disease. The objective of this study was to determine the efficacy of three treatments (nonpharmacological therapy, fludrocortisone, and domperidone). Phase I assessed the compliance, safety, and efficacy of nonpharmacological measures. Phase II was a double‐blind randomized controlled crossover trial of the two medications. Primary outcome measures consisted of the orthostatic domain of the Composite Autonomic Symptom Scale (COMPASS‐OD), a clinical global impression of change (CGI), and postural blood pressure testing via bedside sphygmomanometry (Phase I) or tilt table testing (Phase II). For the 17 patients studied, nonpharmacological therapy did not significantly alter any outcome measure. Both medications improved the CGI and COMPASS‐OD scores. There was a trend towards reduced blood pressure drop on tilt table testing, with domperidone having a greater effect. © 2007 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Schoffer, Kerrie L" sort="Schoffer, Kerrie L" uniqKey="Schoffer K" first="Kerrie L." last="Schoffer">Kerrie L. Schoffer</name>
</noRegion>
<name sortKey="Henderson, Robert D" sort="Henderson, Robert D" uniqKey="Henderson R" first="Robert D." last="Henderson">Robert D. Henderson</name>
<name sortKey="Henderson, Robert D" sort="Henderson, Robert D" uniqKey="Henderson R" first="Robert D." last="Henderson">Robert D. Henderson</name>
<name sortKey="O Maley, Karen" sort="O Maley, Karen" uniqKey="O Maley K" first="Karen" last="O'Maley">Karen O'Maley</name>
<name sortKey="O Sullivan, John D" sort="O Sullivan, John D" uniqKey="O Sullivan J" first="John D." last="O'Sullivan">John D. O'Sullivan</name>
<name sortKey="O Sullivan, John D" sort="O Sullivan, John D" uniqKey="O Sullivan J" first="John D." last="O'Sullivan">John D. O'Sullivan</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D15 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002D15 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:29167FC968A8A883DC9A9FDAF9A429074AD4225F |texte= Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |